A peptide vaccine targeting the CMV antigen pp65 in children and young adults with recurrent high-grade glioma and medulloblastoma: a phase 1 trial Summary This phase 1 clinical trial investigates the safety and immunogenicity of a peptide Read More
Tags :phase
Author Correction: Intracerebroventricular bivalent CAR T cells targeting EGFR and
Author Correction: Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial Summary A Phase 1 clinical trial investigated the safety and feasibility of intracerebroventricular (ICV) administration of bivalent CAR Read More
Correction: Multicenter phase Ib/II study of second-line durvalumab and tremelimumab
Correction: Multicenter phase Ib/II study of second-line durvalumab and tremelimumab in combination with paclitaxel in patients with biomarker-selected metastatic gastric cancer Summary A multicenter phase Ib/II clinical trial investigated the efficacy and safety Read More
Mobilizing antigen-presenting mast cells in anti-PD-1-refractory triple-negative breast cancer: a
Mobilizing antigen-presenting mast cells in anti-PD-1-refractory triple-negative breast cancer: a phase 2 trial Summary This phase 2 trial explores a novel approach to overcome resistance to anti-PD-1 immunotherapy in triple-negative breast cancer (TNBC). Researchers aim to Read More
A phase Ib/II trial of atezolizumab with cobimetinib or idasanutlin in metastatic estrogen receptor positive breast cancer Summary This phase Ib/II trial investigated the efficacy and safety of atezolizumab (an immunotherapy drug) combined Read More